From: Comparing the cost effectiveness of harm reduction strategies: a case study of the Ukraine
Infection averted | Â | Monte Carlo Simulation | Deterministic | ||||
---|---|---|---|---|---|---|---|
 |  | Combined | NSP | OST | Combined | NSP | OST |
Cost | Â | 1,574,559.00 | 247,108.68 | 1,206,760.80 | 1,565,967.17 | 247,148.20 | 1,199,134.00 |
 | Std | 580,415.89 | 67,045.82 | 419,480.75 |  |  |  |
 | Upper CI(95%) | 1,585,935.20 | 248,422.78 | 1,214,982.60 |  |  |  |
 | Lower CI(95%) | 1,563,182.90 | 245,794.58 | 1,198,539.00 |  |  |  |
Effect | Â | 1,848.76 | 506.98 | 1,053.10 | 1,848.74 | 506.98 | 1,053.03 |
 | Std | 6.78 | 5.33 | 5.39 |  |  |  |
 | Upper CI(95%) | 1,848.89 | 507.08 | 1,053.21 |  |  |  |
 | Lower CI(95%) | 1,848.63 | 506.88 | 1,052.99 |  |  |  |
CE | Â | 851.68 | 487.41 | 1,145.91 | 847.05 | 487.49 | 1,138.75 |
 | Std | 95.06 | 54.01 | 128.57 |  |  |  |
 | Upper CI(95%) | 853.55 | 488.47 | 1,148.43 |  |  |  |
 | Lower CI(95%) | 849.82 | 486.35 | 1,143.39 |  |  |  |
QALY | Â | Â | Â | Â | Â | Â | Â |
 |  | combined | NSP | OST | combined | NSP | OST |
Cost | Â | 1,563,571.10 | 247,577.10 | 1,195,319.80 | 1,565,967.17 | 247,148.20 | 1,199,134.00 |
 | Std | 579,705.31 | 66,864.85 | 418,960.03 |  |  |  |
 | Upper CI(95%) | 1,574,933.30 | 248,887.65 | 1,203,531.40 |  |  |  |
 | Lower CI(95%) | 1,552,208.90 | 246,266.55 | 1,187,108.10 |  |  |  |
Effect | Â | 4,183.51 | 2,970.21 | 2,599.08 | 4,183.51 | 2,970.21 | 2,599.04 |
 | Std | 7.47 | 5.69 | 5.71 |  |  |  |
 | Upper CI(95%) | 4,183.66 | 2,970.32 | 2,599.19 |  |  |  |
 | Lower CI(95%) | 4,183.36 | 2,970.10 | 2,598.97 |  |  |  |
CE | Â | 373.75 | 83.35 | 459.90 | 374.32 | 83.21 | 461.38 |
 | Std | 95.06 | 54.01 | 128.57 |  |  |  |
 | Upper CI (95%) | 374.57 | 83.55 | 460.93 |  |  |  |
 | Lower CI (95%) | 372.92 | 83.15 | 458.87 |  |  |  |